Abstract: Disclosed herein are compositions and methods for delivering compositions to a subject in need of treatment for epilepsy. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering cannabidiol and CBD-containing compositions to subjects in need of treatment for epilepsy.
Type:
Grant
Filed:
July 24, 2023
Date of Patent:
April 2, 2024
Assignee:
POVIVA CORP
Inventors:
John Docherty, Christopher Andrew Bunka
Abstract: Disclosed herein are compositions and methods for delivering compositions to a subject in need of treatment for epilepsy. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering cannabidiol and CBD-containing compositions to subjects in need of treatment for epilepsy.
Type:
Grant
Filed:
July 24, 2023
Date of Patent:
March 19, 2024
Assignee:
POVIVA CORP
Inventors:
John Docherty, Christopher Andrew Bunka
Abstract: Disclosed herein are compositions and methods for oral delivery of nicotine and nicotine derivatives. In one embodiment the nicotine is delivered in an oral packets, pouches, or sachets.
Type:
Application
Filed:
March 22, 2022
Publication date:
September 28, 2023
Applicant:
POVIVA CORP.
Inventors:
John Docherty, Christopher Andrew Bunka
Abstract: Disclosed herein are compositions and methods for oral delivery of nicotine and nicotine derivatives. In one embodiment the nicotine is delivered in an oral packets, pouches, or sachets.
Type:
Grant
Filed:
March 22, 2022
Date of Patent:
July 18, 2023
Assignee:
POVIVA CORP.
Inventors:
John Docherty, Christopher Andrew Bunka
Abstract: Disclosed herein are compositions and methods for delivering cannabidiol to subject in need of hypertension treatment. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering the cannabidiol-containing compositions.
Type:
Grant
Filed:
July 5, 2022
Date of Patent:
June 6, 2023
Assignee:
POVIVA CORP.
Inventors:
John Docherty, Christopher Andrew Bunka
Abstract: Disclosed herein are compositions and methods for delivering cannabidiol to subject in need of hypertension treatment. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering the cannabidiol-containing compositions.
Type:
Grant
Filed:
July 5, 2022
Date of Patent:
June 6, 2023
Assignee:
POVIVA CORP.
Inventors:
John Docherty, Christopher Andrew Bunka
Abstract: Disclosed herein are methods, compositions and kits for treating a viral infection, for example, COVID-19, MERS and SARS. The disclosed compositions provide for enhanced delivery of the disclosed antiviral agents.
Type:
Grant
Filed:
April 19, 2021
Date of Patent:
April 26, 2022
Assignee:
POVIVA CORP.
Inventors:
John Docherty, Christopher Andrew Bunka
Abstract: Disclosed herein are methods, compositions and kits for treating a viral infection, for example, COVID-19, MERS and SARS. The disclosed compositions provide for enhanced delivery of the disclosed antiviral agents.
Type:
Application
Filed:
April 19, 2021
Publication date:
February 24, 2022
Applicant:
POVIVA CORP.
Inventors:
John Docherty, Christopher Andrew Bunka
Abstract: Disclosed herein are methods, compositions and kits for treating a viral infection, for example, COVID-19, MERS and SARS. The disclosed compositions provide for enhanced delivery of the disclosed antiviral agents.
Type:
Application
Filed:
April 19, 2021
Publication date:
October 28, 2021
Applicant:
POVIVA CORP.
Inventors:
John Docherty, Christopher Andrew Bunka
Abstract: Aspects described herein relate to lipophilic active agent infused tobacco leaves and/or tobacco materials and methods of use thereof. More particularly, aspects described herein relate to tobacco leaves and/or tobacco materials infused with lipophilic active agents that provide enhanced bioavailability of the lipophilic active agents in a subject, and that mask unpleasant tastes.
Type:
Application
Filed:
September 13, 2019
Publication date:
September 23, 2021
Applicant:
POVIVA CORP.
Inventors:
John Docherty, Christopher Andrew Bunka
Abstract: Aspects described herein relate to improved beverage compositions with lipophilic active agents and related methods. More particularly, aspects described herein relate to stable ready-to-drink beverage compositions comprising lipophilic active agents, methods of making such compositions, and methods of use.
Type:
Application
Filed:
April 26, 2021
Publication date:
August 5, 2021
Applicant:
POVIVA CORP.
Inventors:
John Docherty, Christopher Andrew Bunka, Thomas James Ihrke
Abstract: Aspects described herein relate to lipophilic active agent infused tobacco leaves and/or tobacco materials and methods of use thereof. More particularly, aspects described herein relate to tobacco leaves and/or tobacco materials infused with lipophilic active agents that provide enhanced bioavailability of the lipophilic active agents in a subject, and that mask unpleasant tastes.
Type:
Application
Filed:
March 29, 2021
Publication date:
July 15, 2021
Applicant:
POVIVA CORP.
Inventors:
John Docherty, Christopher Andrew Bunka
Abstract: Aspects described herein relate to improved methods for infusing food and beverage compositions with lipophilic active agents. More particularly, aspects described herein relate to improved methods for infusing food and beverage compositions with lipophilic active agents using tapioca starch or related compounds. Lipophilic active agents include cannabinoids, nicotine, nonsteroidal anti-inflammatories (NSAIDs), and vitamins.
Type:
Application
Filed:
February 26, 2021
Publication date:
June 17, 2021
Applicant:
POVIVA CORP.
Inventors:
John Docherty, Christopher Andrew Bunka, Thomas James Ihrke
Abstract: Aspects described herein relate to food and beverage compositions infused with lipophilic active agents and methods of use for the treatment of a variety of disorders. More particularly, aspects described herein relate to food and beverage compositions infused with lipophilic active agents such as cannabinoids, nicotine, nonsteroidal anti-inflammatories (NSAIDs), and vitamins, that provide enhanced bioavailability of the lipophilic active agents in a subject, and that mask unpleasant tastes of lipophilic active agents.